GlassScriptPhysician profile
Daniel A Horton
NPI 1629619846
$1,906.06
in general payments reported to CMS, 2019-2025
20 companies · $538 in 2025
The $538 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $316 · 2022: $118 · 2023: $248 · 2024: $685 · 2025: $538.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $373.64 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $284.88 | 2024-2025 | Xtampza, Belbuca |
| Antares Pharma, INC. | $271.28 | 2024-2025 | Xyosted |
| Scilex Pharmaceuticals INC. | $204.34 | 2023-2025 | Ztlido |
| Stryker Corporation | $153.36 | 2021-2023 | Multigen 2 |
| Abbvie INC. | $140.81 | 2024-2025 | |
| Nevro Corp. | $81.82 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $70.81 | 2024 | |
| Jazz Pharmaceuticals INC. | $39.38 | 2021 | |
| Optinose US, INC. | $36.11 | 2021-2022 | |
| Alk-Abello, INC | $34.59 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $33.41 | 2021 | |
| Kaleo, INC. | $30.11 | 2022 | |
| Intersect Ent, INC. | $28.93 | 2021 | |
| International Rehabilitative Sciences, INC | $27.86 | 2024 | Rs 4i Plus Sequential Stimulator |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.12 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.09 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.70 | 2022 | |
| Csl Behring | $14.80 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Horton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.